Patients with a history of nocturnal hypoglycemia might consider daytime administration to reduce this risk, along with use of second-generation basal insulin analogs like Gla-300, with lower hypoglycemia risk, especially nocturnal hypoglycaemia [15]. Here, INS is linked to Hypoglycemia.